Skip to content

Epidemiology of Risk Factors for Hospital-acquired Pneumonia (HAP) in Intensive Care Unit (ICU) Patients

Epidemiology of Risk Factors for Hospital-acquired Pneumonia in ICU Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02779933
Enrollment
310
Registered
2016-05-23
Start date
2011-01-31
Completion date
2016-05-31
Last updated
2016-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventilator-Associated Pneumonia

Keywords

Hospital-acquired Pneumonia, Epidemiology, Risk Factors

Brief summary

A retrospective, observational study compiled data from all consecutively admitted patients older than 18 years at ICU University Hospital in Olomouc in the period from 1 January 2011 to 31 December 2015 who fulfilled the criteria of HAP. The aim was to determine the severity of the specific risk factors of early and late HAP. Risk factors were divided into factors from the patient and from the hospitalization. Furthermore, an assessment of their relationship to mortality.

Detailed description

The primary outcome was to evaluate the relationship between risk factors and the development of early/late onset HAP. Another outcome was assessed to evaluate the relation of risk factors early/late onset HAP and mortality. The crucial time for evaluating the presence of risk factors was their presence from hospital admission to the moment of fulfilling the criteria for pneumonia. Risk factors were divided into two groups, on factors of the patient (uncontrollable) and by the hospitalization (controllable). Factors of the patient were: gender (male/female), age at enrollment (years), Acute Physiology and Chronic Health Evaluation II (APACHE II) score, multi-organ failure presence (MOF), hypertension, ischemic heart disease (IHD) chronic renal insufficiency (CRI), continual use of renal replacement therapy (CRRT), acute renal insufficiency (ARI), diabetes mellitus (DM), Chronical Obstructive Pulmonary Disease (COPD), immunosuppression or leukopenia \<1.5x109/l, impaired consciousness with Glasgow coma scale (GCS) \<8 tracheotomy, head trauma/neurosurgery, abdominal surgery-thoracotomy. Side factors hospitalization were: aspiration into the lungs, urgent intubation, reintubated, sedation, bronchoscopy, nasogastric intubation, enteral feeding continuously/intermittently intolerance of enteral nutrition, physiotherapy, repeated transport of the patient from the ICU, length of hospital stay, length of mechanical ventilation, 30-day mortality.

Interventions

OTHEREpidemiology od HAP

no intervention

Sponsors

University Hospital Olomouc
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Hospital-Acquired Pneumonia * Intensive Care patient * X-ray signs of pneumonia

Exclusion criteria

* Age less than 18 years * Negative culture findings in the airways * Low quantity of culture findings

Design outcomes

Primary

MeasureTime frameDescription
30-day mortality (non modifiable HAP risk factor)30 daysYes/No assessment

Secondary

MeasureTime frameDescription
Duration of hospital stay before onset of HAP (non modifiable HAP risk factor)7 daysAssessment if hospital stay was present, or for how long
Repeated transport of the patient from the ICU (non modifiable HAP risk factor)30 daysAssessment if repeated transports were present or not
Implementation of physiotherapy before onset of HAP (non modifiable HAP risk factor)7 daysAssessment if physiotherapy was provided or not
Intolerance of enteral nutrition before onset of HAP (non modifiable HAP risk factor)7 daysYes/No assessment
Nasogastric intubation before onset of HAP (non modifiable HAP risk factor)7 daysYes/No assessment
Bronchoscopy before onset of HAP (non modifiable HAP risk factor)7 daysYes/No assessment
Sedation administration before onset of HAP (non modifiable HAP risk factor)7 daysYes/No assessment
Urgent tracheal intubation before onset of HAP (non modifiable HAP risk factor)7 daysYes/No assessment
Tracheal reintubation before onset of HAP (non modifiable HAP risk factor)7 daysYes/No assessment
Aspiration into the lungs before onset of HAP (non modifiable HAP risk factor)7 daysYes/No assessment
Condition after abdominal surgery or thoracotomy before onset of HAP (modifiable HAP risk factor)7 days
Duration of mechanical ventilation before onset of HAP (non modifiable HAP risk factor)7 daysAssessment if mechanical ventilation was provided, or for how long
Condition after tracheotomy before onset of HAP (modifiable HAP risk factor)7 daysYes/No assessment
Impaired consciousness with Glasgow coma scale low than 8 before onset of HAP (modifiable HAP risk factor)7 daysYes/No assessment
Immunosuppression or leukopenia less than 1.5x10 9/L before onset of HAP (modifiable HAP risk factor)7 daysYes/No assessment
Chronical Obstructive Pulmonary Disease before onset of HAP (modifiable HAP risk factor)7 daysYes/No assessment
Diabetes mellitus before onset of HAP (modifiable HAP risk factor)7 daysYes/No assessment
Acute renal insufficiency without renal replacement therapy before onset of HAP (modifiable HAP risk factor)7 daysYes/No assessment
Acute renal insufficiency with renal replacement therapy before onset of HAP (modifiable HAP risk factor)7 daysYes/No assessment
Chronic renal insufficiency before onset of HAP (modifiable HAP risk factor)7 daysYes/No assessment
Ischemic heart disease before onset of HAP (modifiable HAP risk factor)7 daysYes/No assessment
Hypertension before onset of HAP (modifiable HAP risk factor)7 daysYes/No assessment
Multi-organ failure before onset of HAP (modifiable HAP risk factor)7 daysYes/No assessment
Condition after head trauma or neurosurgery before onset of HAP (modifiable HAP risk factor)7 daysYes/No assessment

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026